By the end of this session, attendees will be able to:
- Understand the potential storage requirements for autologous and allogeneic therapies and associated materials
- Recognize the challenges to scaling the advanced therapy supply chain
- Describe the differences between small molecule / biologics and advanced therapy supply chains